Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$128M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$32.6M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$28.6M |
| 4 |
Tyler Technologies
TYL
|
+$26.9M |
| 5 |
Brown & Brown
BRO
|
+$19.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$284M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Alibaba
BABA
|
+$158M |
| 5 |
Amazon
AMZN
|
+$104M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.17% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRNB
1651
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.31M | ﹤0.01% |
42,200
+26,600
| +171% | +$1.46M |
|
1652
SM Energy
SM
$3.07B
| $2.31M | ﹤0.01% |
205,250
+4,800
| +2% | +$54K |
|
1653
AZZ Inc
AZZ
$3.52B
| $2.3M | ﹤0.01% |
50,100
+1,200
| +2% | +$55.1K |
|
1654
Matthews International
MATW
$763M
| $2.3M | ﹤0.01% |
60,296
+1,000
| +2% | +$38.2K |
|
|
WIRE
1655
DELISTED
Encore Wire Corp
WIRE
| $2.29M | ﹤0.01% |
39,933
+800
| +2% | +$45.9K |
|
1656
Southside Bancshares
SBSI
$916M
| $2.28M | ﹤0.01% |
61,318
+1,200
| +2% | +$44.6K |
|
1657
Kadant
KAI
$3.69B
| $2.28M | ﹤0.01% |
21,600
+600
| +3% | +$63.2K |
|
|
NP
1658
DELISTED
Neenah, Inc. Common Stock
NP
| $2.28M | ﹤0.01% |
32,300
+600
| +2% | +$42.3K |
|
1659
Patrick Industries
PATK
$3.67B
| $2.27M | ﹤0.01% |
65,063
+1,350
| +2% | +$47.2K |
|
1660
First Bancorp
FBNC
$2.29B
| $2.27M | ﹤0.01% |
56,800
+1,000
| +2% | +$39.9K |
|
1661
Denny's
DENN
$264M
| $2.26M | ﹤0.01% |
113,700
+700
| +0.6% | +$13.9K |
|
1662
STAAR Surgical
STAA
$1.37B
| $2.25M | ﹤0.01% |
63,900
+1,500
| +2% | +$52.7K |
|
1663
ADT
ADT
$7.24B
| $2.25M | ﹤0.01% |
283,200
+1,700
| +0.6% | +$13.5K |
|
1664
B&G Foods
BGS
$360M
| $2.25M | ﹤0.01% |
125,200
+3,100
| +3% | +$55.6K |
|
1665
Strategy Inc Common Stock Class A
MSTR
$94B
| $2.24M | ﹤0.01% |
157,000
+3,000
| +2% | +$42.8K |
|
|
RCM
1666
DELISTED
R1 RCM Inc. Common Stock
RCM
| $2.23M | ﹤0.01% |
171,700
+5,900
| +4% | +$76.6K |
|
1667
Greif
GEF
$3.59B
| $2.22M | ﹤0.01% |
50,200
+1,100
| +2% | +$48.6K |
|
1668
Nelnet
NNI
$4.46B
| $2.22M | ﹤0.01% |
38,100
+700
| +2% | +$40.8K |
|
1669
Fate Therapeutics
FATE
$111M
| $2.22M | ﹤0.01% |
113,300
+2,400
| +2% | +$47K |
|
|
CSW
1670
CSW Industrials, Inc.
CSW
$4.2B
| $2.21M | ﹤0.01% |
28,749
+700
| +2% | +$53.9K |
|
|
FOE
1671
DELISTED
Ferro Corporation
FOE
| $2.21M | ﹤0.01% |
149,100
+2,900
| +2% | +$43K |
|
1672
Kearny Financial
KRNY
$412M
| $2.21M | ﹤0.01% |
159,664
-1,700
| -1% | -$23.5K |
|
1673
Tactile Systems Technology
TCMD
$301M
| $2.21M | ﹤0.01% |
32,700
+900
| +3% | +$60.8K |
|
1674
Arbor Realty Trust
ABR
$2.25B
| $2.2M | ﹤0.01% |
153,551
+1,800
| +1% | +$25.8K |
|
|
GTY
1675
Getty Realty Corp
GTY
$1.6B
| $2.2M | ﹤0.01% |
66,809
+1,600
| +2% | +$52.6K |
|